Who are the top shareholders of the Laxmi Dental?

The top shareholders of Laxmi Dental include promoters, with Rajesh Vrajlal Khakhar holding 16.91%, and 27 Foreign Institutional Investors (FIIs) owning 34.24%. The highest public shareholder is Orbimed Asia II Mauritius Limited at 22.41%, while individual investors hold 6.49%.

The top shareholders of Laxmi Dental include a mix of promoters, institutional investors, and public shareholders. The majority shareholders are the promoters, with Rajesh Vrajlal Khakhar holding the highest stake at 16.91%. Among institutional investors, 27 Foreign Institutional Investors (FIIs) collectively hold 34.24%, while 16 mutual fund schemes account for 11.89% of the shares. The highest public shareholder is Orbimed Asia II Mauritius Limited, which holds 22.41%. Additionally, individual investors have a combined holding of 6.49%.

Has Laxmi Dental declared dividend?

No Dividend History Available

Who are the peers of the Laxmi Dental?

Laxmi Dental's peers include Syngene Intl., Dr Lal Pathlabs, Poly Medicure, Indegene, Vijaya Diagnost., Krsnaa Diagnost., Tarsons Products, Suraksha Diagno., and 3B Blackbio. In terms of management risk, growth, and capital structure, Laxmi Dental is rated as good, while its 1-year return is not available for comparison.

Peers: The peers of Laxmi Dental are Syngene Intl., Dr Lal Pathlabs, Poly Medicure, Indegene, Vijaya Diagnost., Krsnaa Diagnost., Tarsons Products, Suraksha Diagno., and 3B Blackbio.<BR><BR>Quality Snapshot: Excellent management risk is observed at Dr Lal Pathlabs and Laxmi Dental, while Good management risk is found at Syngene Intl., Poly Medicure, Indegene, Vijaya Diagnost., and the rest. Average management risk is noted at Krsnaa Diagnost. and Suraksha Diagno., while Below Average management risk is seen at Tarsons Products and Sastasundar Ven. In terms of Growth, Laxmi Dental shows Good growth, while Average growth is found at Poly Medicure and Indegene, and Below Average growth is observed at Syngene Intl., Dr Lal Pathlabs, Vijaya Diagnost., Krsnaa Diagnost., and the rest. Excellent capital structure is noted at Syngene Intl., Dr Lal Pathlabs, Poly Medicure, Indegene, Vijaya Diagnost., and Krsnaa Diagnost., while Good capital structure is seen at Laxmi Dental and Suraksha Diagno., and Below Average capital structure is found at Tarsons Products and Sastasundar Ven.<BR><BR>Return Snapshot: The peer with the highest 1-year return is 3B Blackbio at 84.85%, while the peer with the lowest is Tarsons Products at -6.26%. Laxmi Dental's 1-year return is not available for comparison. Additionally, Krsnaa Diagnost. and Tarsons Products have negative six-month returns.

What does Laxmi Dental do?

Laxmi Dental Ltd is a small-cap healthcare services company that specializes in dental care, with recent net sales of 607 Cr and a net profit of 43 Cr as of March 2025. The company was incorporated in 2004 and became publicly listed in 2024.

Overview: <BR>Laxmi Dental Ltd operates in the healthcare services industry and is categorized as a small-cap company.<BR><BR>History: <BR>Laxmi Dental Limited was incorporated in 2004 as Laxmi Dental Export Private Limited. The company underwent a name change to Laxmi Dental Private Limited in June 2024 and subsequently converted to a public company as Laxmi Dental Limited in August 2024. The most recent quarterly results reported net sales and net profit for March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 607 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 43 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 2,600 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 99.00 <BR>Industry P/E: 53 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.43 <BR>Return on Equity: 12.82% <BR>Price to Book: 12.31 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

How big is Laxmi Dental?

As of 24th July, Laxmi Dental Ltd has a market capitalization of 2,572.00 Cr, with recent Net Sales of 234.51 Cr and a Net Profit of 22.48 Cr. Shareholder's Funds are reported at 42.47 Cr, and Total Assets amount to 123.26 Cr as of March 2024.

As of 24th July, Laxmi Dental Ltd has a market capitalization of 2,572.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, Laxmi Dental reported Net Sales of 234.51 Cr and a Net Profit of 22.48 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, with Shareholder's Funds reported at 42.47 Cr and Total Assets amounting to 123.26 Cr.

When is the next results date for Laxmi Dental?

The next results date for Laxmi Dental is 12 August 2025.

The next results date for Laxmi Dental is scheduled for 12 August 2025.

How has been the historical performance of Laxmi Dental?

Laxmi Dental has shown significant growth over the past three years, with net sales increasing from 161.63 Cr in Mar'23 to 239.11 Cr in Mar'25, and profit after tax turning from a loss of 4.45 Cr to a profit of 25.37 Cr. The company's operating profit margin improved from 5.54% to 17.7%, reflecting a strengthening financial position.

Answer:<BR>The historical performance of Laxmi Dental shows significant growth over the past three years, particularly in revenue and profitability.<BR><BR>Breakdown:<BR>Laxmi Dental's net sales have increased from 161.63 Cr in Mar'23 to 239.11 Cr in Mar'25, reflecting a strong upward trend. The total operating income has followed suit, rising from 161.63 Cr in Mar'23 to 239.11 Cr in Mar'25. The company's operating profit (PBDIT) has also seen substantial growth, moving from 11.17 Cr in Mar'23 to 45.21 Cr in Mar'25, with an operating profit margin that improved from 5.54% to 17.7% over the same period. Profit before tax turned positive, reaching 31.83 Cr in Mar'25, compared to a loss of 4.26 Cr in Mar'23, while profit after tax rose from a loss of 4.45 Cr to a profit of 25.37 Cr. The consolidated net profit increased from a loss of 3.97 Cr in Mar'23 to 31.77 Cr in Mar'25. On the balance sheet, total assets grew significantly from 96.38 Cr in Mar'23 to 278.22 Cr in Mar'25, driven by increases in cash and bank balances and total reserves. Total liabilities also rose, but at a slower pace, from 96.38 Cr to 278.22 Cr, indicating a strengthening financial position. Cash flow from operating activities improved dramatically, reaching 43 Cr in Mar'25, compared to only 8 Cr in Mar'24, contributing to a net cash inflow of 125 Cr in Mar'25, a significant turnaround from previous years.

Which are the latest news on Laxmi Dental?

Why is Laxmi Dental falling/rising?

As of 03-Dec, Laxmi Dental Ltd's stock price is Rs. 250.00, down 5.05% and reaching a 52-week low of Rs. 248.15. The stock has declined 15.67% over the last eight days and underperformed its sector by 4.81% today, indicating a bearish trend despite increased investor participation.

As of 03-Dec, Laxmi Dental Ltd's stock price is falling, currently at Rs. 250.00, which reflects a decrease of Rs. 13.3 or 5.05%. The stock has been on a downward trend, having lost value for the last eight consecutive days, resulting in a total decline of 15.67% during this period. Today, the stock reached a new 52-week low of Rs. 248.15, indicating significant selling pressure. <BR><BR>In terms of performance relative to the market, Laxmi Dental has underperformed its sector by 4.81% today and has seen a substantial decline of 23.16% over the past month, while the benchmark Sensex has gained 1.34% in the same timeframe. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which suggests a bearish trend. <BR><BR>Despite a rise in investor participation, with delivery volume increasing by 34.61% against the 5-day average, the overall sentiment appears negative, contributing to the stock's decline. The liquidity of the stock remains adequate for trading, but the persistent downward movement and recent lows indicate a challenging environment for Laxmi Dental Ltd.

Is Laxmi Dental overvalued or undervalued?

As of December 3, 2025, Laxmi Dental is fairly valued with a PE ratio of 51.40 and an EV to EBITDA of 32.44, showing a more favorable market position compared to peers like Lenskart Solutions and Poly Medicure, despite a recent stock price decline.

As of 3 December 2025, Laxmi Dental's valuation grade has moved from expensive to fair, indicating a more favorable assessment of its market position. The company is currently fairly valued, with a PE ratio of 51.40, an EV to EBITDA of 32.44, and a ROCE of 12.57%. In comparison to peers, Laxmi Dental's PE ratio is significantly lower than Lenskart Solutions, which stands at 240.61, while Poly Medicure is at 53.52, highlighting that Laxmi Dental is more reasonably priced within its sector.<BR><BR>Despite the recent decline in stock price, with a 1-month return of -23.16% compared to a 1.34% return for the Sensex, the company's valuation metrics suggest it is not overvalued. The PEG ratio is notably at 0.00, indicating no growth expectations priced in, which may further support the argument for its fair valuation. Overall, Laxmi Dental appears to be positioned well within the healthcare services industry, especially when compared to its more expensive peers.